Clinical Trials Logo

B-cell Lymphomas (Phase 1) clinical trials

View clinical trials related to B-cell Lymphomas (Phase 1).

Filter by:
  • None
  • Page 1

NCT ID: NCT01897571 Completed - Clinical trials for Primary Mediastinal Large B-Cell Lymphoma

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Start date: June 13, 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label, multicenter, Phase 1/2 study of tazemetostat as a single agent in subjects with advanced solid tumors or with B-cell lymphomas and tazemetostat in combination with prednisolone in subjects with diffuse large B-cell lymphoma (DLBCL).